Abstract

ObjectiveDisruption of the genes encoding either seipin or 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) causes severe congenital generalized lipodystrophy (CGL) in humans. However, the function of seipin in adipogenesis remains poorly defined. We demonstrated recently that seipin can bind the key adipogenic phosphatidic acid (PA) phosphatase lipin 1 and that seipin forms stable dodecamers. As AGPAT2 generates PA, the substrate for lipin 1, we investigated whether seipin might bind both enzymes of this lipid biosynthetic pathway, which is required for adipogenesis to occur.MethodsWe employed co-immunoprecipitation and immunofluorescence methods to determine whether seipin can interact with AGPAT2 and the consequences of this in developing adipocytes. Atomic force microscopy was used to determine whether these interactions involved direct association of the proteins and to define the molecular architecture of these complexes.ResultsOur data reveal that seipin can bind AGPAT2 during adipogenesis and that stabilizing this interaction during adipogenesis can increase the nuclear accumulation of PPARγ. Both AGPAT2 and lipin 1 can directly associate with seipin dodecamers, and a single seipin complex can simultaneously bind both AGPAT2 and lipin with a defined orientation.ConclusionsOur study provides the first direct molecular link between seipin and AGPAT2, two proteins whose disruption causes CGL. Moreover, it provides the first example of an interaction between seipin and another protein that causally influences a key aspect of adipogenesis. Together our data suggest that the critical role of seipin in adipogenesis may involve its capacity to juxtapose important regulators of this process in a multi-protein complex.

Highlights

  • Homozygous disruption of either BSCL2 or AGPAT2, encoding seipin and 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) respectively, causes a very severe congenital generalized lipodystrophy (CGL)

  • Our data reveal that seipin can bind AGPAT2 during adipogenesis and that stabilizing this interaction during adipogenesis can increase the nuclear accumulation of PPARg

  • It provides the first example of an interaction between seipin and another protein that causally influences a key aspect of adipogenesis

Read more

Summary

Introduction

Homozygous disruption of either BSCL2 or AGPAT2, encoding seipin and 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) respectively, causes a very severe congenital generalized lipodystrophy (CGL). Affected individuals display a striking lack of adipose tissue and suffer severe metabolic disease [1e4]. Both seipin and AGPAT2 have critical cell-autonomous roles in adipogenesis, and the loss of these functions is likely to explain the failure of patients to develop adipose tissue [5e9]. Loss of AGPAT2 in preadipocytes causes a failure to induce adipogenic gene expression before TG accumulation would normally occur during adipocyte differentiation [6,9]. Seipin-deficient mouse embryonic fibroblasts (MEFs) display increased lipolysis and consequent loss of lipid accumulation [19,20]; the molecular basis of this observation remains uncertain. The specific loss of 14-3-3b during adipogenesis causes reduced lipid accumulation, but not the failure of adipogenic gene expression observed with

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.